377 related articles for article (PubMed ID: 26291065)
1. Optimization of a multiplex CRISPR/Cas system for use as an antiviral therapeutic.
Kennedy EM; Kornepati AVR; Mefferd AL; Marshall JB; Tsai K; Bogerd HP; Cullen BR
Methods; 2015 Dec; 91():82-86. PubMed ID: 26291065
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.
Yin C; Zhang T; Qu X; Zhang Y; Putatunda R; Xiao X; Li F; Xiao W; Zhao H; Dai S; Qin X; Mo X; Young WB; Khalili K; Hu W
Mol Ther; 2017 May; 25(5):1168-1186. PubMed ID: 28366764
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9 with single guide RNA expression driven by small tRNA promoters showed reduced editing efficiency compared to a U6 promoter.
Wei Y; Qiu Y; Chen Y; Liu G; Zhang Y; Xu L; Ding Q
RNA; 2017 Jan; 23(1):1-5. PubMed ID: 27742910
[TBL] [Abstract][Full Text] [Related]
4. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.
Kennedy EM; Cullen BR
Virology; 2015 May; 479-480():213-20. PubMed ID: 25759096
[TBL] [Abstract][Full Text] [Related]
5. Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing Efficiency.
Fry LE; Peddle CF; Stevanovic M; Barnard AR; McClements ME; MacLaren RE
CRISPR J; 2020 Aug; 3(4):276-283. PubMed ID: 32833533
[TBL] [Abstract][Full Text] [Related]
6. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population.
Morsy SG; Tonne JM; Zhu Y; Lu B; Budzik K; Krempski JW; Ali SA; El-Feky MA; Ikeda Y
BMC Res Notes; 2017 Dec; 10(1):720. PubMed ID: 29221488
[TBL] [Abstract][Full Text] [Related]
7. Expression of CRISPR/Cas single guide RNAs using small tRNA promoters.
Mefferd AL; Kornepati AV; Bogerd HP; Kennedy EM; Cullen BR
RNA; 2015 Sep; 21(9):1683-9. PubMed ID: 26187160
[TBL] [Abstract][Full Text] [Related]
8. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications.
Friedland AE; Baral R; Singhal P; Loveluck K; Shen S; Sanchez M; Marco E; Gotta GM; Maeder ML; Kennedy EM; Kornepati AV; Sousa A; Collins MA; Jayaram H; Cullen BR; Bumcrot D
Genome Biol; 2015 Nov; 16():257. PubMed ID: 26596280
[TBL] [Abstract][Full Text] [Related]
10. Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms.
Dong Z; Qin Q; Hu Z; Chen P; Huang L; Zhang X; Tian T; Lu C; Pan M
Virol Sin; 2019 Aug; 34(4):444-453. PubMed ID: 31218589
[TBL] [Abstract][Full Text] [Related]
11. CRISPR Systems Suitable for Single AAV Vector Delivery.
Stevanovic M; Piotter E; McClements ME; MacLaren RE
Curr Gene Ther; 2022; 22(1):1-14. PubMed ID: 34620062
[TBL] [Abstract][Full Text] [Related]
12. A Single Transcript CRISPR-Cas9 System for Multiplex Genome Editing in Plants.
Tang X; Zhong Z; Ren Q; Liu B; Zhang Y
Methods Mol Biol; 2019; 1917():75-82. PubMed ID: 30610629
[TBL] [Abstract][Full Text] [Related]
13. Efficient viral delivery of Cas9 into human safe harbor.
Hayashi H; Kubo Y; Izumida M; Matsuyama T
Sci Rep; 2020 Dec; 10(1):21474. PubMed ID: 33293588
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
[TBL] [Abstract][Full Text] [Related]
15. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
[TBL] [Abstract][Full Text] [Related]
16. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic In Vivo Gene Editing Achieved by a Hypercompact CRISPR-Cas12f1 System Delivered with All-in-One Adeno-Associated Virus.
Cui T; Cai B; Tian Y; Liu X; Liang C; Gao Q; Li B; Ding Y; Li R; Zhou Q; Li W; Teng F
Adv Sci (Weinh); 2024 May; 11(19):e2308095. PubMed ID: 38408137
[TBL] [Abstract][Full Text] [Related]
18. Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector.
Kabadi AM; Ousterout DG; Hilton IB; Gersbach CA
Nucleic Acids Res; 2014 Oct; 42(19):e147. PubMed ID: 25122746
[TBL] [Abstract][Full Text] [Related]
19. AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.
Li A; Tanner MR; Lee CM; Hurley AE; De Giorgi M; Jarrett KE; Davis TH; Doerfler AM; Bao G; Beeton C; Lagor WR
Mol Ther; 2020 Jun; 28(6):1432-1441. PubMed ID: 32348718
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 as an antiviral against Orthopoxviruses using an AAV vector.
Siegrist CM; Kinahan SM; Settecerri T; Greene AC; Santarpia JL
Sci Rep; 2020 Nov; 10(1):19307. PubMed ID: 33168908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]